文献速递艾滋病与性传播感染病毒性肝炎

HIV与HBV共感染成人脂肪肝的前瞻性队列研究

Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究为北美乙型肝炎研究网络的辅助研究,纳入114名HIV-HBV共感染成人,自2014年4月28日至2018年11月7日接受肝活检并随访中位3年。结果显示约30%存在脂肪肝病(FLD),其中10%为脂肪性肝炎;FLD与非黑人种族、代谢危险因素、致动脉粥样硬化血脂谱及随访期间ALT升高相关。

要点

  • HIV-HBV共感染成人中约30%有脂肪肝病,10%为脂肪性肝炎。
  • FLD与非黑人种族、高血压、高脂血症、糖尿病家族史及ALT升高相关。
  • FLD患者随访期间ALT持续更高,需重视脂肪肝识别与代谢管理。

核心结论

  • 约30%的HIV-HBV共感染成人存在脂肪肝病,其中10%为脂肪性肝炎。
  • 脂肪肝病与非黑人种族、代谢危险因素、致动脉粥样硬化血脂谱及随访期间ALT升高相关。
  • 在HIV-HBV共感染中识别脂肪肝病和管理不良代谢谱至关重要。

研究设计与样本

  • 前瞻性队列研究,为乙型肝炎研究网络的辅助研究。
  • 2014年4月28日至2018年11月7日纳入114名HIV-HBV共感染成人,接受肝活检并随访中位3年。
  • 脂肪性肝炎基于脂肪变、气球样变和窦周纤维化判定;FLD定义为≥5%脂肪变和/或脂肪性肝炎。

主要发现

  • 中位年龄49岁,93%为男性,51%为黑人,93% HIV RNA<400 copies/mL,83% HBV DNA<1000 IU/mL。
  • 30%有FLD(20%脂肪变,10%脂肪性肝炎)。
  • FLD者中位甘油三酯171 vs 100 mg/dL(P<.01),小密LDL 44 vs 29 mg/dL(P<.01),HDL-2-C 9 vs 12 mg/dL(P=.001)。

关键数值与推荐

  • 调整年龄、性别和酒精使用后,白人及其他种族相比黑人种族与FLD相关的OR分别为8.49和16.54。
  • ALT每翻倍OR 3.13,高血压OR 10.93,高脂血症OR 4.36,糖尿病家族史OR 5.38(均P<.05)。
  • 脂肪性肝炎或单纯脂肪变(相比无)与随访期间ALT升高相关,分别为1.93倍和1.34倍(P<.001),调整年龄、性别和HBV DNA。

临床怎么用

  • 对HIV-HBV共感染成人应评估脂肪肝病及代谢危险因素。
  • 关注甘油三酯、小密LDL、HDL-2-C等血脂指标及随访ALT变化。
  • 针对代谢异常进行管理可能有助于改善共感染者的肝脏结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis B virus (HBV) and fatty liver disease (FLD) are common in human immunodeficiency virus (HIV). Correlates of FLD and its relationship with alanine aminotransferase (ALT) were examined longitudinally in HIV-HBV coinfection. METHODS: From 28/4/2014-7/11/2018, 114 HIV-HBV adults had liver biopsy and were followed for a median of 3 years (ancillary study of Hepatitis B Research Network). Steatohepatitis was based on presence of steatosis, ballooning, and perisinusoidal fibrosis. FLD was defined as ≥5% steatosis and/or steatohepatitis. RESULTS: Median age was 49 years, 93% were male, 51% black, 93% had HIV RNA <400 copies/mL and 83% HBV DNA <1000 IU/mL. Thirty percent had FLD (20% steatosis, 10% steatohepatitis). Those with FLD had higher median triglyceride (171 vs 100 mg/dL, P < .01) and small, dense LDL (44 vs 29 mg/dL, P < .01) and lower HDL-2-C (9 vs 12 mg/dL, P = .001). After adjusting for age, sex, and alcohol use, white and other versus black race (ORs, 8.49 and 16.54, respectively), ALT (OR, 3.13/doubling), hypertension (OR, 10.93), hyperlipidemia (OR, 4.36), and diabetes family history (OR, 5.38) were associated with having FLD (all P < .05). Steatohepatitis or steatosis alone (vs none) was associated with higher ALT over time (1.93 and 1.34 times higher, respectively; P < .001), with adjustment for age, sex, and HBV DNA. CONCLUSIONS: About 30% with HIV-HBV coinfection had FLD including 10% with steatohepatitis. FLD was associated with non-black race, metabolic risks, an atherogenic lipid profile, and elevated ALT over time. Thus, identification of FLD and management of adverse metabolic profiles are critically important in HIV-HBV coinfection. Clinical Trial Registration. NCT01924455.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Khalili M, King WC, Kleiner DE, et al. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clin Infect Dis. 2021. PMID: 32869840. doi:10.1093/cid/ciaa1303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。